Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

• Published in: Diabetes care Vol. 45; no. 11; pp. 2753 - 2786
• Main Authors: Davies, Melanie J., Aroda, Vanita R., Collins, Billy S., Gabbay, Robert A., Green, Jennifer, Maruthur, Nisa M., Rosas, Sylvia E., Del Prato, Stefano, Mathieu, Chantal, Mingrone, Geltrude, Rossing, Peter, Tankova, Tsvetalina, Tsapas, Apostolos, Buse, John B.
• Format: Journal Article
• Language: English
• Published: United States American Diabetes Association 01.11.2022
• Subjects: Adult; Consensus; Consensus Report; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2; Disease management; Europe; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide 1; Glucagon-Like Peptide-1 Receptor; Health care; Health risks; Humans; Hyperglycemia; Hypoglycemic Agents; Physical activity; Sodium-glucose cotransporter; Subgroups; United States; United States; Europe

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The target audience is the full spectr...